Brief: Automodular announces normal course issuer bid
April 7 (Reuters) - Automodular Corp AMh.V
* Automodular announces normal course issuer bid
* Automodular Corp - Normal course issuer bid will begin on
April 13, 2017 and will terminate on April 12, 2018
* Automodular - Under terms of normal course issuer bid, co
may acquire up to 808,905 of its common shares, representing 10%
of 8.1 million common shares
Source text for Eikon: ID:nCCN50sdMv
Further company coverage: AMh.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsCanada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group
Canada's HLS Therapeutics Q1 revenue rises on Vascepa growth, reaffirms 2026 guidance
Canada's HLS Therapeutics Q4 revenue slightly beats on Vascepa strength
Brief: Esperion Partner announces HLS Therapeutics received approval Of NILEMDO for the reduction of LDL-cholesterol in canadians at risk of cardiovascular disease
Brief: HLS Therapeutics announces Health Canada approval of NILEMDO for the reduction of LDL-Cholesterol in Canadians at risk of cardiovascular disease